Glucagon-Like Peptide-1 Receptor Agonists: all 1,407 studies that test it
Page 11 of 15. Open to participants first (306), then studies with results posted, then the rest; newest registration first within each.
- A Clinical Trial Comparing Semaglutide in Healthy People Who Eat and Take the Medicine at Different TimesCompletedNCT04513704Phase 1
- Efficacy and Safety of Liraglutide on Body Weight in Obese Subjects or Overweight Subjects With Co-morbiditiesStatus unknownNCT04487743Phase 3
- Semaglutide for the Treatment of Cognitive Dysfunction in Major Depressive DisorderCompletedNCT04466345Phase 2
- Semaglutide and Dapagliflozin in Diabetic Patients With Different PathophysiologyActive, not recruitingNCT04451837Phase 2
- 16-week Flexible vs. 8-week Semaglutide TitrationStatus unknownNCT04447859Phase 3
- A Study to Test How Different Doses of BI 456906 Are Tolerated in Japanese Men With a Body Mass Index (BMI) Between 23 and 40 kg/m2CompletedNCT04384081Phase 1
- Exercise and GLP-1 RA on Insulin SecretionStatus unknownNCT04383197Not applicable
- Laparocopic Sleeve Gastrectomy With or Without Liraglutide in Obese PatientsCompletedNCT04325581Phase 3
- Liraglutide in the Prevention of Type 2 Diabetes After Gestational DiabetesCompletedNCT04324229Not applicable
- Exenatide Treatment in Parkinson's DiseaseStatus unknownNCT04305002Phase 2
- SUSTAIN SWITCH: A Research Study to Compare Two Dose Schedules of Semaglutide Taken Once Weekly in People With Type 2 DiabetesWithdrawnNCT04287179Phase 3
- The Effects of Semaglutide on Taste, Tongue Tissue Transcriptome, Gastric Emptying and Central Neural Response in Women With PCOS and ObesityCompletedNCT04263415Phase 4
- First Research Study to Look at How Two Medicines, NNC0480-0389 and Semaglutide, Work Together in Healthy People, in People With High Body Weight and in People With DiabetesCompletedNCT04259801Phase 1
- A Research Study to Compare Two Different Forms of Once-weekly Semaglutide in Two Different Injection PensCompletedNCT04238962Phase 1
- Exenatide Once Weekly Over 2 Years as a Potential Disease Modifying Treatment for Parkinson's DiseaseCompletedNCT04232969Phase 3
- A Research Study Looking at the Comparability (Bioequivalence) of Two Versions of SemaglutideCompletedNCT04228354Phase 1
- A Research Study Looking at the Comparability (Bioequivalence) of Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or ObesityCompletedNCT04187300Phase 1
- Effect of Liraglutide vs CPAP on Cardiometabolic Outcomes in Obstructive Sleep ApneaCompletedNCT04186494Not applicable
- A Research Study Looking at Similarity Between Once-weekly Semaglutide Versions for Different Injection PensCompletedNCT04152915Phase 1
- Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial DiseaseStatus unknownNCT04146155Phase 4
- Clinical Study on the Improvement of Diabetic Neuropathic Pain by LiraglutideStatus unknownNCT04137328Not applicable
- Combined Effects of GLP-1 Analogue and Exercise on Maintenance of Weight Loss and Health After Very-low Calorie DietStatus unknownNCT04122716Phase 4
- A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (C) Semaglutide TabletsCompletedNCT04109508Phase 1
- A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide TabletsCompletedNCT04097600Phase 1
- Renal Effects of Treatment With Empagliflozin Alone or in Combination With Semaglutide in Patients With Type 2 Diabetes and AlbuminuriaStatus unknownNCT04061200Phase 4
- Effect of Liraglutide on the Metabolic Profile in Patients With Type 2 Diabetes and Cardiovascular DiseaseWithdrawnNCT04057261Phase 3
- Effect of Liraglutide on Microbiome in ObesityStatus unknownNCT04046822Phase 4
- A Research Study of How Semaglutide Works in People With Disease Affecting the Heart and/or Blood Vessels and Type 2 DiabetesCompletedNCT04032197Phase 1
- Metformin vs Metformin Combined With GLP-1RA (Glucagon-like Peptide 1 Receptor Agonist) on Overweight/Obese PCOS PatientsStatus unknownNCT04029272Phase 4
- A Research Study of How Oral Semaglutide Tablets Work in Healthy People Who Are ChineseCompletedNCT04016974Phase 1
- A Research Study to Compare Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or ObesityTerminatedNCT04012255Phase 1
- The Effect of Liraglutide on the GITStatus unknownNCT04008290Phase 4
- Effects of Benaglutide on Weight and Gut Microbiota in Obese PatientsStatus unknownNCT03986008Phase 3
- Semaglutide Treatment On Coronary ProgressionCompletedNCT03985384Phase 4
- Effectiveness of Exenatide Plus Dapagliflozin on 24 Hour Glucose Variability Measured by CGM. A Proof of Concept.CompletedNCT03970044Phase 4
- Treatment of Bile Acid Malabsorption With LiraglutideCompletedNCT03955575Phase 4
- Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients With Type 2 Diabetes MellitusStatus unknownNCT03948347Not applicable
- Triple Therapy in T1DMActive, not recruitingNCT03899402Phase 2/3
- Liraglutide Effect in Atrial FibrillationActive, not recruitingNCT03856632Phase 4
- A Research Study to Look at How Semaglutide Affects Gastric Emptying in People With ObesityCompletedNCT03842202Phase 1
- Haemodynamic Effects of GLP-1 and Glucagon in Healthy Male VolunteersCompletedNCT03835013Not applicable
- Study for Beinaglutide Versus Glargine Therapy in Glycemic Variability of Type 2 Diabetes MellitusCompletedNCT03829891Not applicable
- Dulaglutide in Diabetic Patients, Relationship Between Arterial Stiffness, Endothelial Function, Clinical and Laboratory VariablesCompletedNCT03824002Phase 4
- A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 DiabetesActive, not recruitingNCT03811561Phase 3
- To Predict Weight Loss Response to Liraglutide (Saxenda®), From fMRI-based Determination of Food Cue ReactivityCompletedNCT03795701Not applicable
- A Research Study to Look at How Insulin 287 and Semaglutide Work in the Body of People With Type 2 Diabetes When Taken Alone or TogetherCompletedNCT03789578Phase 1
- A Research Study of NNC0165-1875 Alone or Together With Semaglutide in People Who Are Overweight or ObeseCompletedNCT03707990Phase 1
- Effects of Liraglutide on the Cognitive Function in Patients With Type 2 Diabetes MellitusCompletedNCT03707171Phase 3
- The Use of Liraglutide in Brain DeathCompletedNCT03672812Phase 3
- Effects of GLP-1 RAs on Weight and Metabolic Indicators in Obese PatientsStatus unknownNCT03671733Phase 3
- Dulaglutide and Insulin MicrosecretiON in Type 1 DiabetesCompletedNCT03668470Phase 2
- GLP1R in Parkinson's DiseaseStatus unknownNCT03659682Phase 2
- Researching an Effect of GLP-1 Agonist on Liver STeatosis (REALIST)Status unknownNCT03648554Phase 4
- Targeting Beta Cell Dysfunction With Liraglutide or Golimumab in Longstanding T1DCompletedNCT03632759Early Phase 1
- Testosterone Replacement Therapy and Liraglutide Effects on Weight Loss in Hypogonadism.CompletedNCT03619330Phase 4
- A Research Study to Look at Similarity Between Semaglutide Versions in Different Injection ToolsCompletedNCT03598621Phase 1
- Effect and Safety of Benaglutide or Metformin in Patients With Simple Obesity Who Have Inadequate Weight ControlStatus unknownNCT03593668Phase 4
- A Study to Test Different Doses of BI 456906 in Patients With ObesityCompletedNCT03591718Phase 1
- Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver DiseaseCompletedNCT03590626Not applicable
- A Research Study of NNC0165-1562 and Semaglutide in People Who Are Overweight or ObeseCompletedNCT03574584Phase 1
- Weight Loss With Intensive Lifestyle Modifications Plus Bariatric Surgery Versus Liraglutide 3 mgCompletedNCT03534310Not applicable
- The Effect of Liraglutide on Pancreatic Hormones and Its SizeCompletedNCT03520062Not applicable
- Effects of GLP-1 Agonists on CArdiac Steatosis Evaluated by Magnetic Resonance ImagingCompletedNCT03498001Not applicable
- Effects of Liraglutide in Chronic Obstructive Pulmonary DiseaseCompletedNCT03466021Phase 4
- Effects of Exenatide on Motor Function and the BrainCompletedNCT03456687Phase 1
- Effect of Liraglutide on Vascular Inflammation in Type-2 DiabetesCompletedNCT03449654Phase 4
- Effect of Exenatide LAR or Dulaglutide on the Variability of 24-hour Heart Rate and Blood Pressure in Type 2 DiabetesStatus unknownNCT03444142Phase 4
- The Effects of Liraglutide on Sudomotor Function and Inflammation in Type 2 DiabetesStatus unknownNCT03426085Phase 2
- Comparing Efficacy and Safety of CinnaGen-liraglutide Versus Victoza® in Patients With Type II DiabetesStatus unknownNCT03421119Phase 3
- Research of Intensive Metabolic Intervention Before Pregnancy in PCOSStatus unknownNCT03383068Phase 4
- Liraglutide on Decreasing Parenteral Support in Short Bowel Patients (SLIPS)WithdrawnNCT03371862Phase 2
- DECREASE: Dapagliflozin Plus Exenatide on Central REgulation of Appetite in diabeteS typE 2CompletedNCT03361098Phase 4
- A Study on How Semaglutide Works on Early Stages of Scar Tissue in the Liver Assessed by Pictures of the LiverCompletedNCT03357380Phase 1
- The Effect of a Liraglutide on IVF in Obese PCOSCompletedNCT03353948Phase 4
- Research of Exenatide for Overweight/Obese PCOS Patients With IGRCompletedNCT03352869Phase 4
- Evaluation of Liraglutide 3.0mg in Patients With Poor Weight-loss and a Suboptimal Glucagon-like Peptide-1 ResponseCompletedNCT03341429Phase 4
- Once Weekly GLP-1 in Persons With Spinal Cord InjuryCompletedNCT03292315Phase 4
- A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese SubjectsCompletedNCT03292185Phase 1
- A Trial to Assess the Pharmacokinetics, Safety and Tolerability of Semaglutide in Healthy Chinese SubjectsCompletedNCT03288740Phase 1
- Trial of EXenatide in Acute Ischaemic StrokeStatus unknownNCT03287076Phase 2
- Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?CompletedNCT03232112Phase 2
- Smoking Cessation Facilitated by Glucagon-like Peptide-1 (GLP-1) AnaloguesCompletedNCT03204396Phase 2
- Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 456906 in Healthy Male VolunteersCompletedNCT03175211Phase 1
- Effect of Exenatide on Cortisol SecretionCompletedNCT03160261Phase 4
- Dose Escalation Trial of Single Subcutaneous Doses of NNC 0113-0217 to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Male SubjectsCompletedNCT03144271Phase 1
- Effects of Glucagon Like Peptide 1 (GLP-1) Analogues on Fluid IntakeCompletedNCT03141632Phase 2
- Antidiabetic Effects on Intrahepatic FatCompletedNCT03068065Phase 4
- Short Term Weight Loss With Liraglutide and Metformin in Infertile Obese PCOS PatientsCompletedNCT03034941Phase 4
- A Study of the Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or ObeseStatus unknownNCT03018665Phase 4
- Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetic CasesCompletedNCT03017352Phase 2
- A Study to Evaluate Pharmacokinetics, Safety and Efficacy of Albiglutide in Pediatric Subjects With Type 2 Diabetes MellitusWithdrawnNCT03015519Phase 3
- Liraglutide as Additional Treatment to Insulin in Patients With Autoimmune Diabetes MellitusStatus unknownNCT03011008Phase 4
- A Trial Investigating the Effect of Oral Semaglutide on the Pharmacokinetics of Furosemide and Rosuvastatin in Healthy SubjectsCompletedNCT03010475Phase 1
- Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus.CompletedNCT03007329Phase 4
- Exenatide and Brown Adipose TissueStatus unknownNCT03002675Phase 4
- Saxenda: Underlying Mechanisms and Clinical OutcomesActive, not recruitingNCT02944500Phase 4
- Ultrasound of the Knee in Obese Patients With Knee Osteoarthritis; Weight MaintenanceCompletedNCT02931383Phase 4
- Clinical Study of Liraglutide in Improving Cardiac Function for Patients With Ischemic CardiomyopathyStatus unknownNCT02930265Not applicable
- Multi-parametric Imaging of the Knee in Obese Patients With Knee Osteoarthritis; Weight MaintenanceCompletedNCT02928679Phase 4
- Biomarkers in Obese Patients With Knee Osteoarthritis; Weight MaintenanceCompletedNCT02928614Phase 4